RE:Is chop zoneYes. It’s a pump and dump for those who did NOT do research on
iCo-019 (Oral Amphotericin
Read the bold one - Lot of people just buying and selling because of volume and trading action. No one knows how big it is once the NR comes in July 1st week You will scratch your head when the SP is $3 :) at July end!! iCo Therapeutics, Inc. (ICOTF)
TheMicrocapNews, Wall St Report, OTC Markets Group, and Vantage Wirereported earlier on iCo Therapeutics, Inc.(ICOTF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
iCo Therapeutics, Inc. identifies existing development stage assets for use in underserved ocular and infectious diseases. The Company owns the international exclusive rights to an oral delivery system - Amphotericin B (Amp B) - for life-threatening infections. Amphotericin B is the gold standard for systemic antifungal drugs. It is one example of a well-established, highly efficacious systemic antifungal drug that has a 50-year history of intravenous therapy.